1.Effects of spontaneous abortion on psychological status of re-pregnant women
Qingqing SU ; Yuan ZENG ; Jingxian CHU ; Jing CHEN ; Liping WU
Chinese Journal of Modern Nursing 2018;24(34):4130-4133
Objective? To investigate the anxiety and depression of pregnant women with spontaneous abortion in the first trimester of pregnancy, and to explore the related influencing factors, so as to provide basis for clinical psychological intervention and treatment. Methods? During August 2015 to February 2016, a total of 70 pregnant women with spontaneous abortions experience and 70 primigravid women at the outpatient department of a ClassⅢ Grade A hospital in Beijing were selected by convenience sampling method. A general questionnaire, Self-rating Anxiety Scale (SAS) and Center for Epidemiologic Studies-Depression Scale (CES-D) were applied in the investigation. Results? There were 8 anxiety cases (11.43%) and 15 depression cases (21.43%) among the 70 pregnant women with spontaneous abortions experience. The scores of SAS and CES-D of the spontaneous abortions group were higher than those of the primigravid group, and the differences were statistically significant (t=2.95,2.51; P< 0.05). The age and education level of the pregnant women were positively correlated with scores SAS (P<0.05). The age, times of spontaneous abortion were positively correlated with scores of CES-D (P< 0.05). Conclusions? There is prominent anxiety and depression in the first trimester of re-pregnancy women with spontaneous abortion experience, which may be related to the age, education level and the times of spontaneous abortions. The psychological status of pregnant women with spontaneous abortion should be assessed early and appropriate psychological intervention should be given when necessary.
2.Historical Evolution and Clinical Application of Famous Classical Formulas Zhulingtang
Na CHEN ; Jingxian GUO ; Yanqi CHU ; Leilei GONG ; Lan ZHANG
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(18):146-155
The classic formula Zhulingtang, derived from the medical work Treatise on Cold Damage (《伤寒论》) compiled by ZHANG Zhongjing, a medical sage in the Eastern Han Dynasty, has been included in the Catalogue of Ancient Classic Formulas (First Batch) published by the National Administration of Traditional Chinese Medicine in 2018. Using the method of textual research, this study systematically reviewed ancient and modern literature to conduct a historical and textual analysis of Zhulingtang, including its origin, composition, dosage, processing, decoction methods, efficacy, and applications. A total of 733 pieces of relevant information related to Zhulingtang were collected, involving 206 ancient Chinese medical texts, with 52 of them providing detailed records of the composition, dosage, processing, and efficacy of Zhulingtang. The results of the analysis showed that Zhulingtang was composed of Polyporus, Poria, Alismatis Rhizoma, Asini Corii Colla, and Talcum. Polyporus and Poria should be used without their peels, Asini Corii Colla should be stir-fried with clam powder, and Talcum should be ground into powder or soaked in water. Based on the conversion of ancient and modern dosages, Polyporus, Poria, Alismatis Rhizoma, and Talcum, 15.63 g for each one, were decocted with 800 mL of water to 400 mL. Then the drug residue was removed, and 15.63 g of Asini Corii Colla was added to the drug juice for melting by heating. The decoction should be taken warm, 140 mL each time, three times a day. Zhulingtang has the effects of promoting diuresis, nourishing yin, and clearing heat, and it is mainly used to treat water-heat combination syndrome, characterized by symptoms such as difficult urination, fever, and thirst. Modern research indicates that Zhulingtang is commonly used to treat diseases such as cirrhotic ascites, chronic glomerulonephritis, nephrotic syndrome, diarrhea, and urinary tract infections. This study provides key information about the famous formula Zhulingtang, which can serve as a reference for further development and research on its application.
3.Clinical efficacy of acupuncture combined with extracorporeal shock wave therapy in the treatment of piriformis syndrome
Delin CHU ; Jingxian CHEN ; Qiang ZHANG ; Chunlei WU ; Puyuan MA ; Dongsheng YU
Chinese Journal of Primary Medicine and Pharmacy 2023;30(6):901-904
Objective:To evaluate the clinical efficacy of acupuncture combined with extracorporeal shock wave therapy in the treatment of piriformis syndrome.Methods:Eighty patients with piriformis syndrome who received treatment in Huaihe Energy Occupational Disease Prevention Hospital Rehabilitation Medicine Center from February 2021 to December 2022 were included in this study. They were divided into a treatment group ( n = 40) and a control group ( n = 40) according to different treatment methods using a retrospective cohort study design. The treatment group was treated with acupuncture combined with extracorporeal shock wave therapy, once every 7 days for 3 consecutive weeks. The control group was treated with extracorporeal shock wave therapy alone once every 7 days for 3 consecutive weeks.Pre- and post-treatment visual analogue scale scores and clinical efficacy were compared between the two groups. Results:There was no significant difference in baseline data between the two groups (all P > 0.05). After treatment, the visual analogue scale score decreased in each group. After adjusting for covariates, there was no significant difference in visual analogue scale score between the two groups ( F = 112.38, P < 0.001). After adjusting the pre-treatment visual analogue scale score, the post-treatment visual analogue scale score in the treatment group was lower than that in the control group [1.417 (95% CI: 1.151-1.683)]. The total response rate in the treatment group was 97.5% (39/40), which was significantly higher than 82.5% (33/40) in the control group ( Z = -2.03, P = 0.042). Conclusion:Acupuncture combined with extracorporeal shock wave therapy is highly effective on piriformis syndrome.
4.Historical evolution and clinical application of classical prescription Yigongsan
Na CHEN ; Jingxian GUO ; Yanqi CHU ; Leilei GONG ; Xinhai JIANG ; Xiao HU ; Lan ZHANG
China Pharmacy 2024;35(1):119-123
Yigongsan, derived from QIAN Yi’s Key to Therapeutics of Children’s Diseases in the Song Dynasty, is a classic pediatric prescription that is included in the Catalogue of Ancient Classic Prescriptions (the Second Batch of Pediatrics) released by the National Administration of Traditional Chinese Medicine in 2022. This paper verifies and analyzes the historical origin, composition, dosage, processing, decoction method and efficacy of Yigongsan by systematically combing ancient books and modern documents. As a result, Yigongsan is composed of five herbs: Panax ginseng, Poria cocos, Atractylodes macrocephala, Citrus reticulata and Glycyrrhiza uralensis, of which P. cocos should be peeled, A. macrocephala is fried with soil, G. uralensis is roasted with honey while P. ginseng and C. reticulata are raw products. According to the dosage of ancient and modern times, each medicinal herb must be ground into fine powder, 1.6 g for each, added with 300 mL of water, 5 pieces of Zingiber officinale, and 2 Ziziphus jujuba, decocted together to 210 mL, and taken before meals. In ancient books, Yigongsan is used to treat vomiting, diarrhea, spleen and stomach deficiency, chest and abdominal distension, and lack of appetite, etc. Modern research showed that Yigongsan could also be used in the diseases of immune system, respiratory system, blood system, etc., involving infantile anorexia, asthma, anemia, tumors and so on.